NorthWest Biotherapeutics Inc (NWBO)

[FeMike]

We all know why NW stock was hammered after 5/10/22.

NWBO was hammered during NYAS because the very first slide showing results, which has been anticipated for years, said:

PFS was not significantly different between the DCVax-L arm and placebo arm: p=0.47

That's it. It was very poorly presented from an investor perspective.

There were foul players involved as well, no doubt, but their efforts could have easily been negated had NWBO:

1) Changed the endpoints on clinicaltrials.gov as soon as they finished the SAP
2) Presented the new, successful endpoints first rather than the old, (pseudo)failed endpoints.

That's all it would have taken, and we'd still be trading above $2 and likely higher, thus reducing dilution, while waiting for the next big event. But NWBO management are a bunch of limp wristed, weak minded buffoons.